Low-level light therapy for Zymosan induced arthritis in rats

Ana P. Castano; Tianhong Dai; Tatiana N. Demidova-Rice; Elena V. Salomatina; Anna N. Yaroslavsky; Ilya Yaroslavsky; Richard Cohen; William A Apruzzese; Michael H. Smotrich; Michael R. Hamblin

doi:10.1117/12.698193

21 February 2007 Low-level light therapy for zymosan-induced arthritis in rats

Ana P. Castano, Tianhong Dai, Tatiana N. Demidova-Rice, Elena V. Salomatina, Anna N. Yaroslavsky, Ilya Yaroslavsky, Richard Cohen, William A Apruzzese, Michael H. Smotrich, Michael R. Hamblin

Author Affiliations +

Proceedings Volume 6428, Mechanisms for Low-Light Therapy II; 64280F (2007) https://doi.org/10.1117/12.698193
Event: SPIE BiOS, 2007, San Jose, California, United States

Abstract

It has been known for many years that low level laser (or light) therapy (LLLT) can ameliorate the pain, swelling and inflammation associated with various forms of arthritis. Light is absorbed by mitochondrial chromophores leading to an increase in ATP, reactive oxygen species and/or cyclic AMP production and consequent gene transcription via activation of transcription factors. However, despite many reports about the positive effects of LLLT in medicine, its use remains controversial. Our laboratory has developed animal models designed to objectively quantify response to LLLT and compare different light delivery regimens. In the arthritis model we inject zymosan into rat knee joints to induce inflammatory arthritis. We have compared illumination regimens consisting of a high and low fluence (3 J/cm² and 30 J/cm²), delivered at a high and low irradiance (5 mW/cm2 and 50 mW/cm²) using 810-nm laser light daily for 5 days, with the effect of conventional corticosteroid (dexamethasone) therapy. Results indicated that illumination with 810-nm laser is highly effective (almost as good as dexamethasone) at reducing swelling and that longer illumination time was more important in determining effectiveness than either total fluence delivered or irradiance. Experiments carried out using 810-nm LLLT on excisional wound healing in mice also confirmed the importance of longer illumination times. These data will be of value in designing clinical trials of LLLT.

Citation Download Citation

Ana P. Castano, Tianhong Dai, Tatiana N. Demidova-Rice, Elena V. Salomatina, Anna N. Yaroslavsky, Ilya Yaroslavsky, Richard Cohen, William A Apruzzese, Michael H. Smotrich, and Michael R. Hamblin "Low-level light therapy for zymosan-induced arthritis in rats", Proc. SPIE 6428, Mechanisms for Low-Light Therapy II, 64280F (21 February 2007); https://doi.org/10.1117/12.698193

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
10 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Wound healing

Laser therapeutics

Low level phototherapy

Animal model studies

Inflammation

Acquisition tracking and pointing

Chromophores

Show All Keywords

Keywords/Phrases

Search In:

Publication Years